老年慢加急性肝衰竭患者等待名单死亡率更高,但肝移植后生存率可接受:与年轻患者比较
基于美国器官共享网络2005至2021年数据,比较老年(≥65岁)与年轻(18-64岁)估计慢加急性肝衰竭(Est-ACLF)等待肝移植患者的结局。老年患者30天等待名单死亡率更高(20.4% vs 16.7%),但移植后1年生存率可接受,Est-ACLF-3级为77%。作者认为年龄本身不应视为肝移植禁忌。
要点
- 老年Est-ACLF患者30天等待名单死亡率为20.4%,高于年轻患者的16.7%。
- 老年Est-ACLF-3级患者移植后1年生存率为77%,作者认为可接受。
- 呼吸衰竭是老年患者移植后1年死亡的唯一独立危险因素。
核心结论
- 老年Est-ACLF患者等待名单死亡率显著高于年轻患者,但移植后1年生存率可接受,包括Est-ACLF-3级患者,因此年龄本身不应视为肝移植禁忌。
- 老年合并呼吸衰竭的患者应仔细选择是否进行肝移植。
研究设计与样本
- 利用美国器官共享网络数据库识别2005年至2021年间等待肝移植的成人Est-ACLF患者,分为老年组(≥65岁)和年轻组(18-64岁)。
- 采用Kaplan-Meier生存分析评估生存率,Fine-Gray竞争风险模型评估等待名单生存的危险因素,逻辑回归评估危险因素。
主要发现
- 共有4313例老年患者(14%)和26628例年轻患者(86%)等待肝移植,分别有2142例(49.6%)和16931例(63.5%)接受了移植。
- 老年患者30天等待名单死亡率为20.4%,高于年轻患者的16.7%(P < .0001);在Est-ACLF-2级中为23.7% vs 14.8%(P < .0001),在Est-ACLF-3级中为43.3% vs 29.9%(P < .0001)。
- 老年Est-ACLF 1、2、3级患者移植后1年生存率分别为86.4%、85.5%和77%;年轻患者在所有这些Est-ACLF级别中生存率均更好。
- 校正移植年代后,呼吸衰竭是老年患者移植后1年死亡率增加的唯一独立危险因素。
临床怎么用
- 作者认为年龄本身不应视为肝移植的禁忌证。
- 作者建议对合并呼吸衰竭的老年患者应仔细选择是否进行肝移植。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There is a paucity of studies on older patients (≥65 years) who develop acute on chronic liver failure (ACLF). The objectives of our study were to determine clinical characteristics and outcomes of older patients listed for liver transplantation (LT). METHODS: Adults listed for LT with estimated ACLF (Est-ACLF) between 2005 and 2021 were identified using the United Network for Organ Sharing database and subdivided into older and younger age (18-64 years) groups. Kaplan-Meier survival analyses were used to evaluate survival, and a competing-risk model (Fine-Gray) was used to evaluate risk factors for survival on the waitlist. Logistic regression was done to evaluate risk factors. RESULTS: A total of 4313 older (14%) and 26,628 younger (86%) patients were listed for LT, and 2142 (49.6%) and 16,931 (63.5%) were transplanted, respectively. Older patients had a higher 30-day waitlist mortality than younger patients (20.4% vs 16.7%; P < .0001); this was more pronounced in Est-ACLF-2 (23.7% vs 14.8%; P < .0001) and Est-ACLF-3 (43.3% vs 29.9%; P < .0001). One-year post-LT, patient survival in older patients with Est-ACLF grades 1, 2, and 3 were 86.4%, 85.5%, and 77% respectively; younger patients had better survival across all Est-ACLF grades. When adjusted for transplant eras, respiratory failure was the only independent risk factor for increased 1-year post-LT mortality in older patients. CONCLUSION: Older patients with Est-CLF had significantly higher waitlist mortality than younger patients, but had acceptable 1-year post-LT survival including those with Est-ACLF-3; therefore, age alone should not be considered as a contraindication for LT. Older patients with respiratory failure should be carefully selected for LT.
引用
- Alukal JJ, Li F, Thuluvath PJ, et al. Older Patients With Acute on Chronic Liver Failure Have a Higher Waitlist Mortality, but Acceptable Post Liver Transplantation Survival When Compared to Younger Patients. Clin Gastroenterol Hepatol. 2023. PMID: 38072285. doi:10.1016/j.cgh.2023.11.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。